Role of acoustic radiation force impulse (ARFI) As noninvasive diagnostic tool in focal hepatic lesions / Yasmine Mohamed Gaber Murad ; Supervised Mahasen Abdelrahman Mabrouk , Ayman Mohamed Rashad Amer , Dalia Abdelhamid Omran
Material type:![Text](/opac-tmpl/lib/famfamfam/BK.png)
- دور جهاز قياس المرونة المعتمد على قوة اندفاع الاشعاع الصوتي كآداة تشخصية غير تداخلية فى البؤر الكبدية [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.33.M.Sc.2016.Ya.R (Browse shelf(Opens below)) | Not for loan | 01010110069934000 | |||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.33.M.Sc.2016.Ya.R (Browse shelf(Opens below)) | 69934.CD | Not for loan | 01020110069934000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
Background: Diagnosis of focal hepatic lesions ( FHLs) by modern imaging expose the patients to risks of contrast medium-induced side effects and irradiation hazards. Acoustic Radiation Force Impulse (ARFI) represents a new imaging method able to non-invasively assess the elastic properties of target tissues.Aim Of The Work: This study was designed to assess the validity of ARFI elastography as a non-invasive method for characterization of FHLs especially hepatocellular carcinoma (HCC). Methods: We enrolled 170 participants in the study, 120 patients with FHLs {uFD3E}88 HCC, 13 hemangioma, 13 metastatic, 6 other lesions), 30 patients with liver cirrhosis and 20 person as normal control groups. Patients were subjected to: Demographic, clinical, laboratory tests, abdominal ultrasound, triphasic CT or MRI, liver biopsy in some patients, stiffness of FHLs and liver parenchyma were measured by ARFI. Results: Of 120 patients with FHLs (77.3 % of HCC group were males, with mean age 59.4± 8 years. Among non- HCC group, 50% were males with mean age 49.7±11 years), a Cut off value of 2.59 m/s of liver stiffness (LS) measured by ARFI can predict occurrence of HCC in cirrhotic patients, sensitivity 78.4% and specificity 72%. For liver tumors, the mean stiffness values were 2.2± 0.7m/s for HCC (n=76), 1.96± 0.7 m/s for hemangioma (n=12), and 2.87± 1.07 m/s for metastasis (n=8). Concluson: ARFI could non-invasively provide significant information regarding the tissue stiffness, useful for predicting HCC occurrence in cirrhotic patients and differentiating HCC from metastases and hemangioma from metastases
Issued also as CD
There are no comments on this title.